Large-scale testing (Phase 3)Study completedNCT05286762
What this trial is testing
Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301
Who this might be right for
ADHDAttention Deficit Hyperactivity DisorderADHD - Combined Type+3 more
Cingulate Therapeutics 103